跳到主要內容區塊
:::

新舊儀器參考區間對照表

Print
    公告日期:110-04-26       
    Items 收費碼 新參考區間 舊參考區間
    Direct Bilirubin 25062H Serum/Plasma:
    0.0-0.2 mg/dL
     
    0.0-0.4
    Total Bilirubin 25061I Serum/Plasma: 0.3-1.0 mg/dL
     
    0.2-1.6
    Lipase 25148C Serum/Plasma: 11-82 U/L
     
    13-60
    Cholesterol 25031H (1)血液生物參考區間:依據美國國家膽固醇教育專案對罹患心血管疾病風險建議: 高度風險≧240 mg/dL; 中度風險201-239 mg/dL; 低度風險≦200 mg/dL. (2)Ascites、Body fluid、Pleural Effusion: (A)Transudate: ≦45 mg/dL; (B)Exudate: >45 mg/dL or cholesterol (body fluid) to cholesterol (serum) ratio >0.3  
    Triglycerides 25041E 血液:依據USA Center for Disease Control for cardiovascular risk建議:Normal_<150 mg/dL;Borderline high_150-199 mg/dL;High_200-500 mg/dL;Very high_>500 mg/dL。
    體液: Chylous effusion:≧110 mg/dL
    Pseudochylous effusion:<50 mg/dL 50-110 mg/dL:equivocal
     
    HDL Chol 25032 HDL-C: >40 mg/dL;依據美國國家膽固醇教育專案對罹患心血管疾病風險建議: 高度風險<40 mg/dL;低度風險:≧60 mg/dL。 M: 30-70
    F: 31-79
    LDL 25033 依據美國國家膽固醇教育專案對成人冠狀動脈疾病管理及預防建議(2001): 最佳濃度:<100 mg/dL; 接近或大於最佳濃度:100-129 mg/dL; 中度高濃度:130-159 mg/dL; 高濃度:160-189 mg/dL; 非常高濃度:≧190 mg/dL。  
    Albumin 25001G Serum/Plasma:
    Adult: 3.5 - 5.7 g/dL
    New Born: 2.8 - 4.2 g/dL
     
    3.7-5.3
    Calcium (Arsenazo) 25205C
    25634E
    Serum/Plasma:
    8.6-10.3 mg/dL
    Urine: 100-300 mg/24 hrs
    8.4-10.6
    Creatinine (Jaffe) 25072E Serum/Plasma:
    M: 0.7-1.3 mg/dL
    F: 0.6-1.2 mg/dL
    Urine: M: 14-26 mg/kg/24 hrs;
    F: 11-20 mg/kg/24 hrs
    M: 0.7-1.5
    F: 0.5-1.2
    Glucose 25010E 飯前血糖:70~100 mg/dL;正常空腹血糖<100 mg/dL,疾病性空腹血糖100~125 mg/dL,糖尿病診斷≧126 mg/dL。
    飯後血糖:70~140 mg/dL。
    隨機血糖:<140 mg/dL。
    65-100
    Iron 25211D Serum/Plasma: 50-212 μg/dL
     
    M: 49-181
    F: 37-170
    Lactate 25017H   0.50-2.20 mmol/L
    Magnesium 25215J
    25633F
    Serum/Plasma: 1.9-2.7 mg/dL
    Urine: 24-255 mg/24 hrs
    1.6-2.3
    TIBC /UIBC 25212C TIBC: 205-567 μg/dL
    UIBC: 155-355 μg/dL
    250-400
    Total protein / for Serum and plasma 25002F Serum/Plasma: 6.4-8.9 g/dL
     
    6.4-8.4
    Phosphate 25207A Serum/Plasma: 2.5-5.0 mg/dL
    Urine: 0.3-1.3 g/24 hr
    2.1-4.7

    UREA/BUN

    U-UN

    25071F

    25624H

    Serum/Plasma: 7-25 mg/dL

    Urine: 7-16 g/24 hrs

    7-20

    12-20 g/day

    Uric acid

    U-UA

    25073D

    25626F

    Serum/Plasma:
    M: 4.4-7.6 mg/dL
    F: 2.3-6.6 mg/dL
    Urine: M: 250-800 mg/24 hrs
    F: 250-750 mg/24 hrs
    1.5-7.2
    CRP Latex Normal(CRPN) 28061H Serum/Plasma: < 1 mg/dL
     
    <1.0
    β2- microglobulin
    Beta2- microglobulin (B2M)
    39102 Serum:970-1840 μg/L
     
    M: <2157
    F: <2295
    Haptoglobin(HAPT) 39119 Serum:
    Adults: 44-215 mg/dL
     
    <30-178
    Urinary/CSF protein (UCSFP)

    25635D

    25721F

    Serum/Plasma: N/A
    Urine: 50-80 mg/24 hrs at rest
    CSF: Adults: 15-45 mg/dL;
    Newborns: < 1 month:
    15-130 mg/dL
    CSF: 15-45
    Urine/CSF Albumin 28075 Serum/Plasma: N/A
    Urine: Normal: < 30 mg/24hr Moderately increased: 30-299 mg/24hr, Clinical Albuminuria >= 300
    CSF: 3mo-4y: 0-450 mg/L (0-45mg/dL), > 4y: 100-300 mg/L (10-30 mg/dL)*
    Other: N/A
    <1.9
    Ammonia 25081C Serum/Plasma: 31-123 μg/dL
     
    10-80
    Alkaline Phosphate 25101B Serum/Plasma: 34-104 U/L
     
    42-128
    ALT (IFCC) 25133A Serum/Plasma: 7–52 U/L
     
    0-40
    AST 25131C Serum/Plasma: 13-39 U/L
     
    5-35
    Amylase 25140A
    25632G
    Serum/Plasma: 29-103 U/L
    Urine: Male 16-491 U/L*
    Female 21-447 U/L
    30-110
    CPK (CK) 25121F Serum/Plasma: 30-223 U/L
     
    0-140
    CKMB 25122E Serum/Plasma: 0-24 U/L
     
     
    GGT 25139E Serum/Plasma: 9-64 U/L
     
    M: 8-60
    F: 4-51
    LDH (IFCC) 25111I Serum/Plasma: 140-271 U/L
     
    95-213
    Homocysteine 39447B adult male and females between 5 and 15 μmol/L M: 5.90-16.00
    F: 3.36-20.44
    Carbamazepine 39437E Serum/Plasma: 4–12 μg/mL 4.0-10.0
    Lithium 25225G Serum/Plasma:
    1-1.2 mmol/L (trough)
     
    0.6-1.2
    Phenobarbital 39436 Serum/Plasma: 10–40 μg/mL 15.0-40.0
    Phenytoin 39430 Serum/Plasma: 10–20 μg/mL 10.0-20.0
    Theophylline 39431 Serum/Plasma: 10–20 μg/mL 10.0-20.0
    Sodium 25201G
    25627E
    Serum/Plasma: 136-146 mEq/L
    Urine: 40-220 mEq/24hrs
    135-147
    Potassium 25202F
    25628D
    Serum: 3.5-5.1 mEq/L
    Plasma: 3.4-4.5 mEq/L
    Urine: 25-125 mEq/24 hrs
    3.4-4.7
    Chloride 25203E
    25629C
    Serum/Plasma: 101 – 109 mEq/L
    Urine: 110-250 mEq/24 hrs
    98-107
    Amikacin 39441
    39450
    Consult literature  
    QMS® Everolimus 39122 3-8 ng/mL 3.0-8.0
    CA 15-3 ( BR ) 39109
    39126
    ≦23.5 U/mL <31.3 U/mL
    Cortisol 39302 Single serum AM: 6.7-22.6 ug/dL
    Single serum PM: <10 ug/dL
    Urine (24 hours):58–403 μg/ day
    Single serum AM7-9: 4.3-22.4 ug/dL
    Single serum PM3-5: 3.1-16.7 ug/dL
    DHEA-S 39317 Male: 18y-21y:24-537 ug/dL ; 21y-30y: 85-690 ug/dL; 31y-40y: 106-464 ug/dL; 41y-50y: 70-495 ug/dL; 51y-60y: 38-313 ug/dL; 61y-70y: 24-244 ug/dL; 大於等於71y: 5-253 ug/dL
    Female: 18y-21y:51-321 ug/dL ; 21y-30y: 18-391 ug/dL; 31y-40y: 23-266 ug/dL; 41y-50y: 19-231 ug/dL; 51y-60y: 8-188 ug/dL; 61y-70y: 12-133 ug/dL; 大於等於71y: 7-177 ug/dL
    Male: 80-560 ug/dL
    Female: 35-430 ug/dL
    Postmenopausal: 10-190 ug/dL
    Ferritin 39364 Males: 23.9-336.2 ng/mL
    Females: 11.0-306.8 ng/mL
    Males: 21.81-274.66 ng/mL
    Females: 4.63-204.00 ng/mL
    RBC Folate(加Lyzing) 39363 #N/A 67.74-485.37 ng/mL
    Free T4 39205 0.63-1.18 ng/dL 0.8-1.9 ng/dL
    CA 19-9 ( GI ) 39107 ≦ 35 U/mL <37.0 U/mL
    hFSH 39313
    37323
    Males: 1.27-19.26 mIU/mL
    Females:Mid-Follicular phase: 3.85-8.78 mIU/mL,Mid-Cycle Peak: 4.54-22.51 mIU/mL,Mid-Luteal phase: 1.79-5.12 mIU/mL,Postmenopausal: 16.74-113.59 mIU/mL
    Males: 1.0-8.0 mIU/mL
    Females:
    Follicular phase: 4.0-13.0 mIU/mL
    Mid-Cycle Peak: 5.0-22.0 mIU/mL
    Luteal phase: 2.0-13.0 mIU/mL Postmenopausal: 20.0-138.0 mIU/mL
    hLH 39306
    37321
    (1)Males: 1.24-8.62 mIU/mL
    (2)Females:Mid-Follicular phase: 2.12-10.89 mIU/mL、Mid-Cycle Peak: 19.18-103.03 mIU/mL、Mid-Luteal phase: 1.20-12.86 mIU/mL、Postmenopausal: 10.87-58.64 mIU/mL
    Males: 2.0-12.0 mIU/mL
    Females:
    Follicular phase: 1.0-18.0 mIU/mL
    Mid-Cycle Peak: 24.0-105.0 mIU/mL
    Luteal phase: 0.4-20.0 mIU/mL Postmenopausal: 15.0-62.0 mIU/mL
    TSH 3rd IS 39203 General Population (males and non-pregnant females, aged 18-88): 0.38 - 5.33μIU/mL 0.4-4.0 uIU/mL
    Intact PTH 39252
    39339
    12 – 88 pg/mL 15.6-68.3 pg/mL
    PSA 39104B ≦ 4.0 ng/mL <4.0
    free PSA 39111
    39104
    Free PSA/ Total PSA ratio: (當Total PSA濃度於4~10 ng/mL時, Percent free PSA/Probability of cancer)0-10%/56%, 10-15%/28%, 15-20%/20%, 20-25%/16%, > 25%/8%  
    CA 125 ( OV ) 39106
    37327
    ≦35 U/mL <35.0 U/mL
    Progesterone 39307
    39338
    Males:0.14~2.06 ng/mL
    Females_ Non-pregnancy: Mid-Follicular phase: 0.31-1.52 ng/mL Mid-Luteal phase: 5.16-18.56 ng/mL Postmenopausal: <0.08-0.78 ng/mL Pregnancy: First trimester: 4.73-50.74 ng/mL Second trimester: 19.41-45.30 ng/mL
    Males: <0.2 ng/mL
    Females:
    Follicular phase: <0.3 ng/mL
    Luteal phase: 1.2-15.9 ng/mL Postmenopausal: <0.2 ng/mL
    懷孕:
    first trim: 2.8-147.3 ng/mL
    second trim: 22.5-95.3 ng/mL
    third trim: 27.9-242.5 ng/mL
    Prolactin 39309
    37322
    (1)Male (adult):2.64-13.13 ng/mL。
    (2)Female (adult): (A)Premenopausal: 3.34~26.72 ng/mL; (B)Postmenopausal: 2.74~19.65 ng/mL。
    (1)Male (adult):2.64-13.13 ng/mL。
    (2)Female (adult):1.39-24.20 ng/mL
    ATA (Thyroglobulin Ab) 45054 < 4 IU/mL 0-40 IU/mL
    Total bHCG (5th IS) 39320
    37329
    男性:<0.6 mIU/mL
    女性:<5.0 mIU/mL
    Pregency Screening
    Negative: <5.0 mIU/mL
    Gray Zone: 5.0-25.0 mIU/mL
    Positive: >25.0 mIU/mL
    Total T3 39200 0.74-1.46 ng/mL 82-179 ng/dL
    Total T4 39201 5.7-10.91 ng/dL 4.5-12.5 ug/dL
    Anti-TPO 28827 ≤ 9 IU/mL < 35 IU/mL
    Insulin(IRI) 45030 飯前胰島素(Insulin AC):1.90~23.00 μIU/mL < 29.1 uIU/mL
    AMH 39326 See IFU  
    25 (OH) Vitamin D Total for DxI 39256 Clinical Guideline - Deficient: <20 ng/mL 缺乏: <10 ng/mL
    不足: 10-30 ng/mL
    充足: 30-100 ng/mL
    毒性: >100 ng/mL
    hsTnI 25156 99th Percentile URL: Females: 11.6 pg/mL (8.4 - 18.3)
    Males: 19.8 pg/mL (14.0 - 42.9)
    Overall: 17.5 pg/mL (12.6 - 20.7)
     
    Sensitive Estradiol 39311
    37320
    (1)Males(大於等於19 years old)<31.5 pg/mL
    (2)Post-menopausal females(Not on hormone therapy)(95th Percentile Limit):小於等於25.1 pg/mL
    (3)Non-pregnant females: (A)Early Follicular phase:22.4~115.0 pg/mL, (B)Mid-follicular phase:25.0~115.0 pg/mL, (C)Mid-luteal phase:36.5~246.0 pg/mL, (D)Ovulatory Peak:32.1~517.0 pg/mL.
    (4)Pediatric(95% CI): (A)Pediatric(male and female) (<1 year) 32.6~43.7 pg/mL, (B)Pre-puberty(female)(1~<12 years)<15.0~20.3 pg/mL, (C)Pre-puberty(male)(1~<12 years)<15.0 pg/mL, (D)Pre-puberty(female)(12~<19 years) 162.0~230.0 pg/mL, (E)Pre-puberty(male)(12~<19 years) 30.8~38.7 pg/mL
    Males: 20-77 pg/mL
    Female:
    Follicular:39-189 pg/mL
    Mid-cycle phase: 94-508 pg/mL
    Luteal phase: 48-309 pg/mL
    Postmenopausal: 20-41 pg/mL
    Procalcitonin (PCT) 28723 <0.07 ng/mL  
    BNP 39453 < 100 pg/mL < 100 pg/mL
    :::